CN109464589A - 一种补血汤及其制备方法 - Google Patents
一种补血汤及其制备方法 Download PDFInfo
- Publication number
- CN109464589A CN109464589A CN201811545295.5A CN201811545295A CN109464589A CN 109464589 A CN109464589 A CN 109464589A CN 201811545295 A CN201811545295 A CN 201811545295A CN 109464589 A CN109464589 A CN 109464589A
- Authority
- CN
- China
- Prior art keywords
- blood
- powder
- parts
- radix
- roots
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000014347 soups Nutrition 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 82
- 210000004369 blood Anatomy 0.000 claims abstract description 56
- 239000008280 blood Substances 0.000 claims abstract description 56
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 40
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 40
- 239000003814 drug Substances 0.000 claims abstract description 25
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 18
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 16
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 16
- 241000646357 Monopterus cuchia Species 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 238000009835 boiling Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 241000220215 Moringa Species 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 11
- 239000011812 mixed powder Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 241000157888 Synbranchiformes Species 0.000 claims description 8
- 241000045403 Astragalus propinquus Species 0.000 claims description 5
- 241000222336 Ganoderma Species 0.000 claims description 5
- 235000006533 astragalus Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000008216 herbs Nutrition 0.000 claims description 4
- 238000002604 ultrasonography Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 230000007812 deficiency Effects 0.000 abstract description 14
- 208000011580 syndromic disease Diseases 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 206010067482 No adverse event Diseases 0.000 abstract description 3
- 239000012530 fluid Substances 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 244000179886 Moringa oleifera Species 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 238000011049 filling Methods 0.000 description 6
- 241000208966 Polygala Species 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 208000000044 Amnesia Diseases 0.000 description 4
- 208000031091 Amnestic disease Diseases 0.000 description 4
- 208000037093 Menstruation Disturbances Diseases 0.000 description 4
- 206010027339 Menstruation irregular Diseases 0.000 description 4
- 241001448424 Ophiopogon Species 0.000 description 4
- 229930195210 Ophiopogon Natural products 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- 230000006986 amnesia Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061245 Internal injury Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229940000406 drug candidate Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000003777 experimental drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000471262 Ardisia japonica Species 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241001571354 Dichrocephala Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001299556 Hypericum przewalskii Species 0.000 description 1
- 241001456092 Laportea Species 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000219289 Silene Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241001300193 Speranskia Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000178320 Vaccaria pyramidata Species 0.000 description 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- CUZMQPZYCDIHQL-VCTVXEGHSA-L calcium;(2s)-1-[(2s)-3-[(2r)-2-(cyclohexanecarbonylamino)propanoyl]sulfanyl-2-methylpropanoyl]pyrrolidine-2-carboxylate Chemical compound [Ca+2].N([C@H](C)C(=O)SC[C@@H](C)C(=O)N1[C@@H](CCC1)C([O-])=O)C(=O)C1CCCCC1.N([C@H](C)C(=O)SC[C@@H](C)C(=O)N1[C@@H](CCC1)C([O-])=O)C(=O)C1CCCCC1 CUZMQPZYCDIHQL-VCTVXEGHSA-L 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008950 danggui buxue decoction Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000009270 zilongjin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种中药制备技术领域,特别涉及一种补血汤及其制备方法,所述补血汤包括三七根、黄鳝、灵芝、二色补血草、牛膝、鸡血藤、艾叶、麦冬、远志、黄芪和辣木籽。该补血汤的制备方法包括药材磨成细粉、蒸煮提取、药液浓缩和过滤的步骤。该制备方法简单,流程少,制备所得补血汤能治疗多种血虚证引发的病症,治疗效果好,无不良反应和毒副作用,且不复发。
Description
【技术领域】
本发明涉及中药制备技术领域,具体涉及一种补血汤及其制备方法。
【背景技术】
中医血虚证是指由失血过多,或脾胃虚弱,或血液生化之源不足,或因瘀血阻滞新血不生等原因所导致的血液不足或血液营养功能低下,脏腑组织器官失养的病理状态。临床常见面色淡白或萎黄、毛发不泽、唇舌、爪甲淡白、头晕、视物昏花、心悸、健忘、失眠、乏力等虚弱症候。血虚时,机体造血功能抑制,免疫功能降低,红细胞的酶活性降低,水盐代谢紊乱及细胞内一些信使物质含量异常等。
《黄帝内经》中对于引起血虚证的病因:主要有外感六邪(风邪、湿邪、热邪),内伤七情,劳倦过度,淤血致虚,出血,年迈体衰。中医认为血虚形成的原因,一是血的生成不足,如气虚不能生血,或脏腑功能减退,如脾失健运,胃气虚弱,不能运化水谷精气,难以化生成血液;或来源不足,则血液生化乏源。二是失血过多过快,新生之血来不及补充。三是久病不愈,慢性消耗,或劳神太过,耗伤精血。现代调查研究分析,血虚证的病因依次是情志因素、不良饮食习惯、平素体质、疾病病程、失血史、生育因素、药毒损伤和出生时体质。
目前,血虚证的治疗多采用药物治疗,例如,以当归、川芎、白芍、熟地黄四味药材制成的四物汤,多适用于补血活血,月经不调等营血虚滞症的症状;又如由黄芪和当归两味药以5:1配比制作出的当归补血汤,具有益气生血的功效,用于治疗劳卷内伤,气血虚,阳浮于外之虚热证。此外,例如专利CN201711438310《一种治疗月经失调的滋阴补血中药方及其制备方法》,采用艾麻草、白龙穿彩、斑叶紫金牛、补血草、草血竭、大对经草、蛋不老、弹裂碎米荠、倒扎龙、鱼眼草、疬子草、瑞苓草、王不留行和麦瓶草这14味中药制成的补血中药方,具有滋阴补血、调经止痛和行气利尿之功效,对女性月经失调治疗具有良好效果的滋阴补血药方。又如专利CN20170197476《一种补血中药组合物颗粒及其在化疗引起的骨髓损伤中的应用》,公开了中药组合物的配方主要由骨液、黄芪、党参、大枣、黑木耳、灵芝、蔗糖、糊精和橘子香精为原料制成的补血颗粒,具有滋补肝肾、填髓壮骨、益气生血的功能,对预防和治疗化疗药物引起的骨髓损伤具有明显的保护作用。在疗效上,它这些方剂只针对血虚证引起的单一病症,但很多时候,血虚证在中医临床中很少以单一病证的形式出现,多复合其他病症出现,而且它们容易复发。
【发明内容】
鉴于上述内容,本发明提供一种补血汤及其制备方法,该补血汤能治疗多种血虚证引发的病症,治疗效果好,无毒副和不良反应,且不复发,为后续研究提供实际应用价值。
为达到上述目的,本发明提供了一种补血汤,包括如下重量份数的组分:18-22份三七根、10-13份黄鳝、5-8份灵芝、5-8份二色补血草、8-12份牛膝、9-15份鸡血藤、2-3份艾叶、5-7份麦冬、4-6份远志、11-15份黄芪和0.3-0.8份辣木籽。
优选的,一种补血汤,包括如下重量份数的组分:19份三七根、11份黄鳝、7份灵芝、7份二色补血草、8份牛膝、10份鸡血藤、2.5份艾叶、6份麦冬、5份远志、12份黄芪和0.5份辣木籽。
本发明还提供一种补血汤的制备方法,所述方法包括以下步骤:
(1)按上述重量份数称取三七根、黄鳝、灵芝、二色补血草、牛膝、鸡血藤、艾叶、麦冬、远志、黄芪和辣木籽,用清水洗净后,沥干水分,于55~65℃下烘干24~36h后,放置于研磨机中分别研磨,得到各原料的粉末;
(2)向步骤(1)所得的三七根粉中加入所述三七根粉1~2体积倍的清水,清水温度为40~50℃,超声处理20~30min后,三七根粉置于蒸锅中蒸煮3~6h,获得熟三七根粉提取液;
(3)将步骤(1)所得的黄鳝粉、灵芝粉、二色补血草粉、牛膝粉、鸡血藤粉、艾叶粉、麦冬粉、远志粉、黄芪粉和辣木籽粉混合,将得到的混合粉末放置于砂锅中,加入步骤(2)得到的熟三七根粉提取液,再加入清水,搅拌混匀后,先用大火煮沸3~5min,然后改用小火慢煮,熬至浓度为1.0~1.5g/mL时,关火,将得到的浓缩药液过70~80目筛,所得汤液即为补血汤。
优选的,步骤(2)中,所述超声的功率为250~300W,频率为20~30kHz。
优选的,步骤(2)中,所述蒸锅蒸煮的温度为110-120℃。
优选的,步骤(3)中,所述清水的加入量为混合粉末体积的3~4倍。
本发明的补血汤包含的各主要原料药的作用及功效如下:
熟三七:具有补血作用,能促进血液中红细胞、白细胞、血小板等各类血液细胞分裂生长,增加数目,保持正常水平。
黄鳝:具有补血、补气、消炎、消毒和除风湿等功效。
灵芝:具有提高身体的免疫力,具有补气血、调血糖和控血压的作用。
二色补血草:具有补血、止血、散瘀、益脾和健胃的功效。
牛膝:具有活血祛瘀、补肝肾、强筋骨、引血下行和利尿通淋的功效。
鸡血藤:具有补血造血、抗癌、抗血凝结、扩张血管和治疗关节炎的功效。
艾叶:具有抗菌、抗病毒、平喘、镇咳、祛痰、抗过敏、止血、抗凝血和增强免疫功能等作用。
麦冬:具有养阴润肺、益胃生津和清心除烦等功效,
远志:具有安神益智、交通心肾和祛痰消肿的功效。
黄芪:具有补气、增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。
辣木籽:具有增强免疫力、排毒、塑身、抗老化、抗癌,并对多种慢性及重大疾病都有极大的改善功效。
本发明的有益效果是:
1、本发明各组分经过科学配伍,协同作用,配伍出具有益气补血,健胃益脾,平肝利肾和润肺清心的补血汤,它能有效治疗多种血虚证,且不复发。中医认为,脾胃为主血生化之源,将血虚与脾胃虚弱等同起来。本发明的药剂以补血效果为主要功效,添加了具有补气功效的黄鳝和黄芪,还添加了具有健脾和胃的二色补血草和麦冬,从补气和健脾和胃的方面来增强补血效果。
2、本发明的组分中不含有任何辅料,采用具有抗菌和抗病毒效果又具有浓烈香气的艾叶,就能用来代替辅料。此外,本发明的药方,组分都为无毒中药,无毒副作用。
3、本发明只需经过药材磨成细粉、蒸煮提取、药液浓缩和过滤的步骤,就能制备出补血汤,制备方法简单,条件易掌控,流程少,制备出的补血汤疗效好。
【具体实施方式】
以下实施例用于说明本发明,但不用来限制本发明的范围。在不背离本发明精神和实质的情况下,对本发明方法、步骤或条件所作的修改或替换,均属于本发明的范围。
实施例1:
1、原料配比:
一种补血汤,包括如下重量份数的组分:18份三七根、10份黄鳝、5份灵芝、5份二色补血草、8份牛膝、9份鸡血藤、2份艾叶、5份麦冬、4份远志、11份黄芪和0.3份辣木籽。
2、制作方法:
(1)按上述重量份数称取三七根、黄鳝、灵芝、二色补血草、牛膝、鸡血藤、艾叶、麦冬、远志、黄芪和辣木籽,用清水洗净后,沥干水分,于55℃下烘干24h后,放置于研磨机中分别研磨,得到各原料的粉末;
(2)向步骤(1)所得的三七根粉中加入所述三七根粉1体积倍的清水,清水温度为40℃,于250W功率、20kHz频率下,超声处理20nim后,三七根粉置于蒸锅中于110℃下蒸煮3h,于下获得熟三七根粉提取液;
(3)将步骤(1)所得的黄鳝粉、灵芝粉、二色补血草粉、牛膝粉、鸡血藤粉、艾叶粉、麦冬粉、远志粉、黄芪粉和辣木籽粉混合,将得到的混合粉末放置于砂锅中,加入步骤(2)得到的熟三七根粉提取液,再加入上述混合粉末3体积倍的清水,搅拌混匀后,先用大火煮沸3min,然后改用小火慢煮,熬至浓度为1.0g/mL时,关火,将得到的浓缩药液过70目筛,所得汤液即为补血汤。
实施例2:
1、原料配比:
一种补血汤,包括如下重量份数的组分:20份三七根、11.5份黄鳝、6.5份灵芝、6.5份二色补血草、10份牛膝、12份鸡血藤、2.5份艾叶、6份麦冬、5份远志、13份黄芪和0.55份辣木籽。
2、制作方法:
(1)按上述重量份数称取三七根、黄鳝、灵芝、二色补血草、牛膝、鸡血藤、艾叶、麦冬、远志、黄芪和辣木籽,用清水洗净后,沥干水分,于60℃下烘干30h后,放置于研磨机中分别研磨,得到各原料的粉末;
(2)向步骤(1)所得的三七根粉中加入所述三七根粉1.5体积倍的清水,清水温度为45℃,于275W功率、25kHz频率下,超声处理25nim后,三七根粉置于蒸锅中于115℃下蒸煮4.5h,获得熟三七根粉提取液;
(3)将步骤(1)所得的黄鳝粉、灵芝粉、二色补血草粉、牛膝粉、鸡血藤粉、艾叶粉、麦冬粉、远志粉、黄芪粉和辣木籽粉混合,将得到的混合粉末放置于砂锅中,加入步骤(2)得到的熟三七根粉提取液,再加入上述混合粉末3.5体积倍的清水,搅拌混匀后,先用大火煮沸4min,然后改用小火慢煮,熬至浓度为1.25g/mL时,关火,将得到的浓缩药液过80目筛,所得汤液即为补血汤。
实施例3:
1、原料配比:
一种补血汤,包括如下重量份数的组分:22份三七根、13份黄鳝、8份灵芝、8份二色补血草、12份牛膝、15份鸡血藤、3份艾叶、7份麦冬、6份远志、15份黄芪和0.8份辣木籽。
2、制作方法:
(1)按上述重量份数称取三七根、黄鳝、灵芝、二色补血草、牛膝、鸡血藤、艾叶、麦冬、远志、黄芪和辣木籽,用清水洗净后,沥干水分,于65℃下烘干36h后,放置于研磨机中分别研磨,得到各原料的粉末;
(2)向步骤(1)所得的三七根粉中加入所述三七根粉2体积倍的清水,清水温度为50℃,于300W功率、30kHz频率下,超声处理30nim后,三七根粉置于蒸锅中于120℃下蒸煮6h,获得熟三七根粉提取液;
(3)将步骤(1)所得的黄鳝粉、灵芝粉、二色补血草粉、牛膝粉、鸡血藤粉、艾叶粉、麦冬粉、远志粉、黄芪粉和辣木籽粉混合,将得到的混合粉末放置于砂锅中,加入步骤(2)得到的熟三七根粉提取液,再加入上述混合粉末4体积倍的清水,搅拌混匀后,先用大火煮沸5min,然后改用小火慢煮,熬至浓度为1.5g/mL时,关火,将得到的浓缩药液过80目筛,所得汤液即为补血汤。
对照组1:
其他步骤与实施例1相同,但补血汤组分换成:8份牛膝、2份艾叶、5份麦冬、4份远志、11份黄芪和0.3份辣木籽。
对照组2:
其他步骤与实施例1相同,但补血汤组分换成:18份三七根、10份黄鳝、5份灵芝、5份二色补血草和9份鸡血藤。
测试试验:
试验药品:实施例1-3和对照组1、2制备得到的补血汤。
试验动物:健康小鼠70只,雌雄各半,体重在18~22g,按性别体重随机的分成7组,每组10只动物,分别为给药组1、2、3、对照组1、2、造模对照组和正常对照组。
试验方法:将实施例1、2、3和对照组1、2所得的补血汤,分别对应灌胃给给药组1、2、3、4、5的小鼠,灌胃剂量按1kg体重灌胃20mL补血汤,每日1次,连续灌胃21d,正常对照组和模型对照组按1kg体重灌胃20mL清水,每日1次,连续灌胃21d。于第8d灌胃后1h,迫使模型对照组、给药组1、2、3、4、5的小鼠进行温水负重游泳20min后,再由眼底静脉丛放血0.5mL,同时每天按1kg体重喂食75g饲料,连续控食饲喂14d,自由饮水,整个试验期间,将小鼠放置于室温20~25℃、湿度45%~55%下培养。
给药21d后,检测以下指标:(1)小鼠体重:连续造模14d后,称取小鼠体重;(2)外周血检测:小鼠称重后,经眼球取血40μl后,将血液放入抗凝液中,混匀后用全自动血球计数仪检测血中的白细胞、红细胞和血红蛋白的数量;(3)脏器系数:经眼球取血后,处死小鼠,解剖并分离出小鼠胸腺和脾脏,洗去血污,除去系膜及脂肪,称量各脏器的质量。根据脏器系数的公式计算各组的脏器系数。
其中,脏器系数(mg/g)=脏器质量(mg)/体质量(g)×100%;
采用SPSS17.0统计学软件进行处理数据,结果用表示,不同组间比较采用方差分析,以P<0.05为显著性差异,P<0.01为极显著性差异,具体见表1。
表1
注:与正常对照组比较*P<0.05;与模型组比较#P<0.05。
由上表可知,与正常对照组比较,模型对照组的小鼠体重、白细胞、红细胞、血红蛋白、脾脏系数和胸腺系数的参数都显著下降;后经灌胃实施例1-3补血汤的给药组1、2、3,各项指标的参数都呈现不同程度的回升,与模型对照组相比较,都显著升高,与正常对照组相比较,不显著;补血汤的组分之间相互协同,共同影响小鼠体重、白细胞、红细胞、血红蛋白、脾脏系数和胸腺系数的参数。
测试试验:
实验药品:实施例1-3所得的补血汤,用四物颗粒为对比药物。
实验对象:将20个具有面色淡白或萎黄,眼睑、口唇、舌质、爪甲的颜色淡白,头晕或眼花、两目干涩、心悸、手脚发麻、多梦、健忘,神疲、手足发麻和脉细无力,任一种或多种症状的体病虚弱的患者,随机分成A、B、C、D组,每组5人。
试验方法:试验时间为3个月。A组每日口服实施例1所得的补血汤1次,每次服用10mL,持续服药2周;B组服用实施例2所得的补血汤,服药方法与A组相同;C组服用实施例3所得的补血汤,服药方法与A组相同;D组每日口服四物颗粒2次,每次服用5g,持续服药3周,后观察病情而定,具体见表2。
表2
由上表可知,本发明提供的补血汤对病体虚弱引起的面色淡白或萎黄,眼睑、口唇、舌质、爪甲的颜色淡白,头晕,或见眼花、两目干涩,心悸,多梦,健忘,神疲,手足发麻、色淡、脉细无力的患者确实有显著疗效,且不复发,同时无不良反应和毒副作用,。
测试试验:
实验药品:实施例1-3所得的补血汤,用乌鸡白凤丸作为对比药物。
实验对象:将20个月经不调的女性患者,随机分成E、F、G、H组,每组5人。
试验方法:试验时间为6个月。E组每日口服实施例1所得的补血汤1次,每次服用10mL,持续服药3个月;F组服用实施例2所得的补血汤,服药方法与E组相同;G组服用实施例3所得的补血汤,服药方法与E组相同;H组每日口服乌鸡白凤丸2次,每次服用6g,持续服药3个月,后观察病情而定,具体见表3。
表3
由上表可知,本发明提供的补血汤对月经不调的患者确实有显著疗效,而且无不良反应和毒副作用。
综上所述,使用本发明提供的补血汤,对于病体虚弱引起的面色淡白或萎黄,眼睑、口唇、舌质、爪甲的颜色淡白,头晕,或见眼花、两目干涩,心悸,多梦、健忘、神疲、手足发麻、色淡、脉细无力和月经不调的患者,具有显著疗效,同时也无不良反应和毒副作用,且不复发。
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对本发明范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明的保护范围应以所附权利要求为准。
Claims (6)
1.一种补血汤,其特征在于,包括如下重量份数的组分:18-22份三七根、10-13份黄鳝、5-8份灵芝、5-8份二色补血草、8-12份牛膝、9-15份鸡血藤、2-3份艾叶、5-7份麦冬、4-6份远志、11-15份黄芪和0.3-0.8份辣木籽。
2.根据权利要求1所述一种补血汤,其特征在于,包括如下重量份数的组分:19份三七根、11份黄鳝、7份灵芝、7份二色补血草、8份牛膝、10份鸡血藤、2.5份艾叶、6份麦冬、5份远志、12份黄芪和0.5份辣木籽。
3.一种如权利要求1或2所述补血汤的制备方法,其特征在于,所述方法包括以下步骤:
(1)按上述重量份数称取三七根、黄鳝、灵芝、二色补血草、牛膝、鸡血藤、艾叶、麦冬、远志、黄芪和辣木籽,用清水洗净后,沥干水分,于55~65℃下烘干24~36h后,放置于研磨机中分别研磨,得到各原料的粉末;
(2)向步骤(1)所得的三七根粉中加入所述三七根粉1~2体积倍的清水,清水温度为40~50℃,超声处理20~30min后,三七根粉置于蒸锅中蒸煮3~6h,获得熟三七根粉提取液;
(3)将步骤(1)所得的黄鳝粉、灵芝粉、二色补血草粉、牛膝粉、鸡血藤粉、艾叶粉、麦冬粉、远志粉、黄芪粉和辣木籽粉混合,将得到的混合粉末放置于砂锅中,加入步骤(2)得到的熟三七根粉提取液,再加入清水,搅拌混匀后,先用大火煮沸3~5min,然后改用小火慢煮,熬至浓度为1.0~1.5g/mL时,关火,将得到的浓缩药液过70~80目筛,所得汤液即为补血汤。
4.根据权利要求3所述一种补血汤的制备方法,其特征在于,步骤(2)中,所述超声的功率为250~300W,频率为20~30kHz。
5.根据权利要求3所述一种补血汤的制备方法,其特征在于,步骤(2)中,所述蒸锅蒸煮的温度为110-120℃。
6.根据权利要求3所述一种补血汤的制备方法,其特征在于,步骤(3)中,所述清水的加入量为混合粉末体积的3~4倍。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811545295.5A CN109464589A (zh) | 2018-12-17 | 2018-12-17 | 一种补血汤及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811545295.5A CN109464589A (zh) | 2018-12-17 | 2018-12-17 | 一种补血汤及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109464589A true CN109464589A (zh) | 2019-03-15 |
Family
ID=65676211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811545295.5A Withdrawn CN109464589A (zh) | 2018-12-17 | 2018-12-17 | 一种补血汤及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109464589A (zh) |
-
2018
- 2018-12-17 CN CN201811545295.5A patent/CN109464589A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1330347C (zh) | 中药滋补膏 | |
CN1895547B (zh) | 一种治疗2型糖尿病的药物及制备方法 | |
CN103920028A (zh) | 一种治疗糖尿病的药物组合物及其制剂的制备方法 | |
CN102579803B (zh) | 一种治疗化疗后白细胞减少症的药物及其制备方法 | |
CN101062339A (zh) | 一种治疗糖尿病的药物 | |
CN108310298A (zh) | 一种具有缓解眼疲劳、防治近视的中药组合物及制备方法 | |
CN104491733A (zh) | 一种中药制剂用于制备治疗贫血、气虚乏力药物中的用途 | |
CN105994867A (zh) | 一种具有提高免疫力的巧克力及其制备方法 | |
CN109939191A (zh) | 一种拮抗肿瘤化疗后骨髓抑制的中药组合物、其制备方法及应用 | |
CN102698099B (zh) | 一种治疗糖尿病的丸剂 | |
CN101954034B (zh) | 一种治疗艾滋病的中药制剂及其制备方法 | |
CN104940516B (zh) | 一种治疗慢性再生障碍性贫血的中药组合物及其制备方法与应用 | |
CN109464589A (zh) | 一种补血汤及其制备方法 | |
CN113826882A (zh) | 防治糖尿病的膳食营养补充剂及其制备工艺 | |
CN101703660B (zh) | 一种抗衰老药物 | |
CN101199761B (zh) | 一种治疗动脉硬化的药物 | |
CN104491318A (zh) | 一种治疗哮喘的中药制剂及其制备方法 | |
CN104435545A (zh) | 一种治疗苯中毒致白细胞减少症的中药制剂 | |
CN104784472A (zh) | 一种降血糖治疗糖尿病的中药组合物 | |
CN111328967A (zh) | 一种制备供高血脂患者食用的保健粥的方法 | |
CN103263580A (zh) | 一种治疗糖尿病的中药组合物 | |
CN103859377A (zh) | 一种有助于降低辐射伤害的养生保健食品配方及其制备方法 | |
CN102764383B (zh) | 一种治疗产后乳头皲裂的乳头护理液 | |
CN106361982A (zh) | 一种治疗糖尿病的药食两用中药制剂及其制备方法 | |
CN101007114B (zh) | 一种肿瘤患者辅助用药品或保健品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190315 |
|
WW01 | Invention patent application withdrawn after publication |